Obesity-Related Single-Nucleotide Polymorphisms and Weight Gain Following First-Line Antiretroviral Therapy
Juan Berenguer(Instituto de Salud Carlos III), Salvador Resino(Instituto de Salud Carlos III), Julián Olalla(Hospital Costa del Sol), Cristina Roca-Oporto, Cristina Díez(Hospital General Universitario Gregorio Marañón), Peré Domingo(Hospital de Sant Pau), María Ángeles Jiménez‐Sousa(Instituto de Salud Carlos III), Juan González‐García(Hospital Universitario La Paz), Carmen Herrero(Complejo Hospitalario de Jaén), David Dalmau(University Hospital Mútua de Terrassa), Francesc Villarroya(Centro de Investigación Biomédica en Red), José M. Bellón(Hospital General Universitario Gregorio Marañón), Inmaculada Jarrín(Instituto de Salud Carlos III)
Cited by 10
Related Papers
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
|Science Immunology|2021|638
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
|Clinical Microbiology and Infection|2020|423
Fibroblast growth factor 21 protects against cardiac hypertrophy in mice
|Nature Communications|2013|371
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342